Abstract
Abstract Transcription factors are important regulators in normal cell proliferation and cancer. Ewing sarcoma is a pediatric bone cancer driven by a translocation between two transcription factor genes, EWSR1 and FLI1, leading to the expression of an aberrant transcription factor, EWS-FLI1. While FLI1 is not expressed, constitutive expression of EWSR1 is retained in Ewing sarcoma cells. However, very little is known about the effect of wild-type EWSR1 on EWS-FLI1 transcriptional activity. EWSR1 and EWS-FLI1 coimmunoprecipitate in a complex together in Ewing sarcoma cells and HEK293T cells. RNA-sequencing in Ewing sarcoma cells revealed a pool of genes coregulated by EWS-FLI1 and EWSR1. Furthermore, loss of EWSR1 in Ewing sarcoma cells inhibits anchorage-independent growth. Taken together, this suggests EWSR1 may play a key role in the transcriptional activity of EWS-FLI1 in Ewing sarcoma biology. Citation Format: Nasiha Ahmed, Jacob Schwartz. EWS-FLI1 partners with EWSR1 to regulate transcription in Ewing sarcoma [abstract]. In: Proceedings of the AACR Special Conference on the Advances in Pediatric Cancer Research; 2019 Sep 17-20; Montreal, QC, Canada. Philadelphia (PA): AACR; Cancer Res 2020;80(14 Suppl):Abstract nr B23.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
